(Q35211947)

7 August 2017

1 reference

title

The use of topical therapies to treat onychomycosis (English)

1 reference

7 August 2017

Aditya K Gupta

1

0 references

author name string

Jennifer E Ryder

series ordinal

2

1 reference

7 August 2017

Robert Baran

series ordinal

3

1 reference

7 August 2017

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

21

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

481-489

1 reference

Epidemiology and prevalence of onychomycosis in HIV-positive individuals

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Onychomycosis in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Topical treatment of nail and skin infections with miconazole, a new broad-spectrum antimycotic

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Treatment of superficial white onychomycosis with topical terbinafine cream

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Clinical trial with clotrimazole cream (Bay b 5097) in dermatophytosis and onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Vitamin E and onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

The topical treatment of onychomycosis using a new combined urea/imidazole preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Treatment of onychomycosis with nail avulsion and topical ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Treatment of Onychomycosis by Partial Nail Avulsion and Topical Miconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Tioconazole nail solution--an open study of its efficacy in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Ciclopirox nail lacquer solution 8% in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

The dermatopharmacologic profile of ciclopirox 8% nail lacquer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Preclinical data and mode of action of amorolfine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Kinetics of amorolfine in human nails.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Absorption of amorolfine through human nail

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900025-1

7 January 2021

10.1016/S0733-8635(03)00025-1

Identifiers

DOI

1 reference

7 August 2017

1 reference